Thymoma and thymic carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations

Teresa Stachowicz-Stencel; Anna Synakiewicz; Marianna Cornet; Andrea Ferrari; Marina Garassino; Jordi Remon Masip; Rod Julien; Calogero Virgone; Dominik T. Schneider; Ines B. Brecht; Tal Ben-Ami; Ewa Bien; Yves Reguerre; Jan Godzinski; Gianni Bisogno; Daniel Orbach; Sabine Sarnacki

doi:10.1002/pbc.29042

Thymoma and thymic carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations

Teresa Stachowicz-Stencel, Anna Synakiewicz, Marianna Cornet, Andrea Ferrari, Marina Garassino, Jordi Remon Masip, Rod Julien, Calogero Virgone, Dominik T. Schneider, Ines B. Brecht, Tal Ben-Ami, Ewa Bien, Yves Reguerre, Jan Godzinski, Gianni Bisogno, Daniel Orbach, Sabine Sarnacki

Research output: Contribution to journal › Article › peer-review

8 Citations (Scopus)

Abstract

Thymic tumors are epithelial tumors arising from the anterior mediastinum and constitute 0.2–1.5% of all adult malignancies but are exceptional in pediatric population. Thymic epithelial tumors (TETs) encompass a variety of histologic subtypes associated with different clinical outcomes. Due to its rarity in children, TETs’ management requires a multidisciplinary approach. However, prognosis remains still poor, especially among patients with thymic carcinoma. This study presents the internationally recognized recommendations for the diagnosis and treatment of thymic tumors in children and adolescents, established by the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) group within the EU-funded project Paediatric Rare Tumours Network - European Registry (PARTNER).

Original language	English
Article number	e29042
Journal	Pediatric Blood and Cancer
Volume	68
Issue number	S4
DOIs	https://doi.org/10.1002/pbc.29042
Publication status	Published - 1 Jun 2021

Keywords

EXPeRT
PARTNER
adolescents
children
guidelines
thymic carcinoma
thymic epithelial tumors
thymoma

Access to Document

10.1002/pbc.29042

Cite this

Stachowicz-Stencel, T., Synakiewicz, A., Cornet, M., Ferrari, A., Garassino, M., Masip, J. R., Julien, R., Virgone, C., Schneider, D. T., Brecht, I. B., Ben-Ami, T., Bien, E., Reguerre, Y., Godzinski, J., Bisogno, G., Orbach, D., & Sarnacki, S. (2021). Thymoma and thymic carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations. Pediatric Blood and Cancer, 68(S4), Article e29042. https://doi.org/10.1002/pbc.29042

@article{1ea5b6e5e8044aabbd054463fdfeb1e6,

title = "Thymoma and thymic carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations",

abstract = "Thymic tumors are epithelial tumors arising from the anterior mediastinum and constitute 0.2–1.5% of all adult malignancies but are exceptional in pediatric population. Thymic epithelial tumors (TETs) encompass a variety of histologic subtypes associated with different clinical outcomes. Due to its rarity in children, TETs{\textquoteright} management requires a multidisciplinary approach. However, prognosis remains still poor, especially among patients with thymic carcinoma. This study presents the internationally recognized recommendations for the diagnosis and treatment of thymic tumors in children and adolescents, established by the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) group within the EU-funded project Paediatric Rare Tumours Network - European Registry (PARTNER).",

keywords = "EXPeRT, PARTNER, adolescents, children, guidelines, thymic carcinoma, thymic epithelial tumors, thymoma",

author = "Teresa Stachowicz-Stencel and Anna Synakiewicz and Marianna Cornet and Andrea Ferrari and Marina Garassino and Masip, {Jordi Remon} and Rod Julien and Calogero Virgone and Schneider, {Dominik T.} and Brecht, {Ines B.} and Tal Ben-Ami and Ewa Bien and Yves Reguerre and Jan Godzinski and Gianni Bisogno and Daniel Orbach and Sabine Sarnacki",

note = "Publisher Copyright: {\textcopyright} 2021 Wiley Periodicals LLC.",

year = "2021",

month = jun,

day = "1",

doi = "10.1002/pbc.29042",

language = "English",

volume = "68",

journal = "Pediatric Blood and Cancer",

issn = "1545-5009",

number = "S4",

}

Stachowicz-Stencel, T, Synakiewicz, A, Cornet, M, Ferrari, A, Garassino, M, Masip, JR, Julien, R, Virgone, C, Schneider, DT, Brecht, IB, Ben-Ami, T, Bien, E, Reguerre, Y, Godzinski, J, Bisogno, G, Orbach, D & Sarnacki, S 2021, 'Thymoma and thymic carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations', Pediatric Blood and Cancer, vol. 68, no. S4, e29042. https://doi.org/10.1002/pbc.29042

TY - JOUR

T1 - Thymoma and thymic carcinoma in children and adolescents

T2 - The EXPeRT/PARTNER diagnostic and therapeutic recommendations

AU - Stachowicz-Stencel, Teresa

AU - Synakiewicz, Anna

AU - Cornet, Marianna

AU - Ferrari, Andrea

AU - Garassino, Marina

AU - Masip, Jordi Remon

AU - Julien, Rod

AU - Virgone, Calogero

AU - Schneider, Dominik T.

AU - Brecht, Ines B.

AU - Ben-Ami, Tal

AU - Bien, Ewa

AU - Reguerre, Yves

AU - Godzinski, Jan

AU - Bisogno, Gianni

AU - Orbach, Daniel

AU - Sarnacki, Sabine

PY - 2021/6/1

Y1 - 2021/6/1

N2 - Thymic tumors are epithelial tumors arising from the anterior mediastinum and constitute 0.2–1.5% of all adult malignancies but are exceptional in pediatric population. Thymic epithelial tumors (TETs) encompass a variety of histologic subtypes associated with different clinical outcomes. Due to its rarity in children, TETs’ management requires a multidisciplinary approach. However, prognosis remains still poor, especially among patients with thymic carcinoma. This study presents the internationally recognized recommendations for the diagnosis and treatment of thymic tumors in children and adolescents, established by the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) group within the EU-funded project Paediatric Rare Tumours Network - European Registry (PARTNER).

AB - Thymic tumors are epithelial tumors arising from the anterior mediastinum and constitute 0.2–1.5% of all adult malignancies but are exceptional in pediatric population. Thymic epithelial tumors (TETs) encompass a variety of histologic subtypes associated with different clinical outcomes. Due to its rarity in children, TETs’ management requires a multidisciplinary approach. However, prognosis remains still poor, especially among patients with thymic carcinoma. This study presents the internationally recognized recommendations for the diagnosis and treatment of thymic tumors in children and adolescents, established by the European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) group within the EU-funded project Paediatric Rare Tumours Network - European Registry (PARTNER).

KW - EXPeRT

KW - PARTNER

KW - adolescents

KW - children

KW - guidelines

KW - thymic carcinoma

KW - thymic epithelial tumors

KW - thymoma

UR - http://www.scopus.com/inward/record.url?scp=85104678923&partnerID=8YFLogxK

U2 - 10.1002/pbc.29042

DO - 10.1002/pbc.29042

M3 - Article

C2 - 33881200

AN - SCOPUS:85104678923

SN - 1545-5009

VL - 68

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

IS - S4

M1 - e29042

ER -

Thymoma and thymic carcinoma in children and adolescents: The EXPeRT/PARTNER diagnostic and therapeutic recommendations

Abstract

Keywords

Access to Document

Other files and links

Cite this